Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 13 (Search time: 0.004 seconds).
previous
1
2
next
Item hits:
Preview
Issue Date
Title
Author(s)
2015
Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non–small-cell lung cancer
Ramalingam, S.S.
;
Shtivelband, M.
;
Soo, R.A.
;
Barrios, C.H.
;
Makhson, A.
;
Segalla, J.G.
;
Pittman, K.B.
;
Kolman, P.
;
Pereira, J.R.
;
Srkalovic, G.
;
Belani, C.P.
;
Axelrod, R.
;
Owonikoko, T.K.
;
Qin, Q.
;
Qian, J.
;
McKeegan, E.M.
;
Devanarayan, V.
;
McKee, M.D.
;
Ricker, J.L.
;
Carlson, D.M.
;
et al.
2013
Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, mutlicentre, randomised phase 3 study
Buikhuisen, W.
;
Burgers, J.
;
Vincent, A.
;
Korse, C.
;
van Klaveren, R.
;
Schramel, F.
;
Pavlakis, N.
;
Nowak, A.
;
Custers, F.
;
Schouwink, J.
;
Gans, S.
;
Groen, H.
;
Strankinga, W.
;
Baas, P.
2013
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
Vermorken, J.
;
Stohlmacher-Williams, J.
;
Davidenko, I.
;
Licitra, L.
;
Winquist, E.
;
Villanueva, C.
;
Foa, P.
;
Rottey, S.
;
SkladowskI, K.
;
Tahara, M.
;
Pai, V.
;
Faivre, S.
;
Blajman, C.
;
Forastiere, A.
;
Stein, B.
;
Oliner, K.
;
Pan, Z.
;
Bach, B.
2015
A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma
Pal, S.
;
Azad, A.
;
Bhatia, S.
;
Drabkin, H.
;
Costello, B.
;
Sarantopoulos, J.
;
Kanesvaran, R.
;
Lauer, R.
;
Starodub, A.
;
Hauke, R.
;
Sweeney, C.
;
Hahn, N.
;
Sonpavde, G.
;
Richey, S.
;
Breen, T.
;
Kremmidiotis, G.
;
Leske, A.
;
Doolin, E.
;
Bibby, D.
;
Simpson, J.
;
et al.
2011
Apixaban versus Warfarin in patients with atrial fibrillation
Granger, C.
;
Alexander, J.
;
McMurray, J.
;
Lopes, R.
;
Hylek, E.
;
Hanna, M.
;
Al-Khalidi, H.
;
Ansell, J.
;
Avezum, A.
;
Atar, D.
;
Bahit, M.
;
Diaz, R.
;
Easton, J.
;
Ezekowitz, J.
;
Garcia, D.
;
Geraldes, M.
;
Gersh, B.
;
Golitsyn, S.
;
Goto, S.
;
Hermosillo, A.
;
et al.
2010
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer
Peeters, M.
;
Price, T.
;
Cervantes, A.
;
Sobrero, A.
;
Ducreux, M.
;
Hotko, Y.
;
Andre, T.
;
Chan, E.
;
Lordick, F.
;
Punt, C.
;
Strickland, A.
;
Wilson, G.
;
Ciuleanu, T.
;
Roman, L.
;
Van Cutsem, E.
;
Tzekova, V.
;
Collins, S.
;
Oliner, K.
;
Rong, A.
;
Gansert, J.
2010
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian gastrointestinal trials group randomized phase III MAX study
Tebbutt, N.
;
Wilson, K.
;
Gebski, V.
;
Cummins, M.
;
Zannino, D.
;
van Hazel, G.
;
Robinson, B.
;
Broad, A.
;
Ganju, V.
;
Ackland, S.
;
Forgeson, G.
;
Cunningham, D.
;
Saunders, M.
;
Stockler, M.
;
Chua, Y.
;
Zalcberg, J.
;
Simes, R.
;
Price, T.
2012
Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: Preclinical evaluation and results of the Phase II DUX Study in chemotherapy-refractory, advanced colorectal cancer
Weickhardt, A.
;
Price, T.
;
Chong, G.
;
Gebski, V.
;
Pavlakis, N.
;
Johns, T.
;
Azad, A.
;
Skrinos, E.
;
Fluck, K.
;
Dobrovic, A.
;
Salemi, R.
;
Scott, A.
;
Mariadason, J.
;
Tebbutt, N.
2010
Functional activity of the OCT-1 protein is predictive of long-term outcome in patients with chronic-phase chronic myeloid leukemia treated with Imatinib
White, D.
;
Dang, P.
;
Engler, J.
;
Frede, A.
;
Osborn, M.
;
Saunders, V.
;
Manley, P.
;
Zrim, S.
;
Hughes, T.
2012
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes
Johnson, D.
;
Brown, F.
;
Clarke, M.
;
Boudville, N.
;
Elias, T.
;
Foo, M.
;
Jones, B.
;
Kulkarni, H.
;
Langham, R.
;
Ranganathan, D.
;
Schollum, J.
;
Suranyi, M.
;
Tan, S.
;
Voss, D.
Discover
Author
4
Price, T.
3
et al.
2
Azad, A.
2
Gebski, V.
2
Oliner, K.
2
Pavlakis, N.
2
Tebbutt, N.
2
Van Cutsem, E.
1
Abizaid, A.
1
Ackland, S.
.
next >
Subject
7
Time Factors
5
Aged, 80 and over
5
Drug Administration Schedule
5
Proportional Hazards Models
4
Antibodies, Monoclonal
4
Fluorouracil
4
Prospective Studies
3
Australia
3
Biomarkers, Tumor
3
Colorectal Neoplasms
.
< previous
next >
Date issued
3
2015
1
2014
2
2013
2
2012
2
2011
3
2010